Market Overview:
The global H2-receptor antagonists market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders, rising geriatric population, and growing demand for combination therapies. By type, the tablets segment is expected to account for the largest share of the global H2-receptor antagonists market in 2018. By application, hospitals are expected to account for the largest share of the global H2-receptor antagonists market in 2018.
Product Definition:
H2-Receptor Antagonists are a type of drug that blocks the action of histamine on H2 receptors. They are used to treat conditions such as peptic ulcers and gastroesophageal reflux disease.
Tablets:
Tablets are small flat packages made of plastic or paper and are commonly used to provide solid oral dosage forms. They can be administered easily by mouth and have a longer shelf life as compared to soft gels. Tablets come in various sizes, shapes, and coatings; some common tablet sizes include 100 mg, 200 mg, 300 mg, 400 mg., 500mg., 600mg., 700mg.
Solutions:
Solution is a group of chemicals that react together to produce the desired effect. Solutions are used in various applications such as medicines, cleaning products, and beauty products. In pharmacology solutions refers to compounds or mixes that when mixed with other substances give combined effect which is greater than individual effects of mixtures. Solutions are also used in H2-receptor antagonists market for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD).
Application Insights:
The clinics segment held the largest share of over 70.0% in 2017. This is due to a high incidence of chronic diseases, such as cardiovascular diseases, cancer and diabetes mellitus that require regular medical checkups and treatment. According to WHO, it is estimated that globally around 17 million people die from these diseases every year. Therefore, increasing the number of patients visiting clinics for healthcare will boost product demand in this segment during the forecast period.
On the other hand, hospitals are expected to be one of the fastest-growing segments owing to growing awareness about better healthcare services among consumers across various regions coupled with rising investments by governments in developing advanced healthcare facilities at an affordable cost for citizens will drive growth over next few years.
Moreover, growing prevalence of respiratory disorders along with rising geriatric population across countries like China India Pakistan.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and high adoption rate of new therapies are some factors responsible for its large share. Moreover, increasing cases of chronic diseases such as respiratory and cardiovascular disorders are expected to drive the demand for H2 receptor antagonists in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments along with private organizations and increasing awareness about advanced treatment options among patients is driving this regional market. In addition, growing investment by major pharmaceutical companies will boost growth further due to improving healthcare infrastructure coupled with rising patient disposable income levels which will result in an increase in demand for these products over the next eight years (from 2018 to 2030).
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for H2-receptor antagonists in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options. This is likely to boost the demand for H2-receptor antagonists in the near future.
- Rising number of smokers: The number of smokers across the globe is rising, which is leading to an increase in cases of chronic obstructive pulmonary disease (COPD). This will create a high demand for H2-receptor antagonists in order to treat COPD patients effectively.
- Technological advancements: The pharmaceutical industry is witnessing rapid advancements in technology, which are resulting in new drug discoveries and approvals by regulatory authorities worldwide. This will fuel the growth of the H2-receptor antagonist market during forecast period 2017 – 2022 . 5) Growing geriatric population: The geriatric population (aged 65 years or above) account for a significant share of total global population and this segment is expected to grow at a fast pace over next few decades owing to improved healthcare facilities and increased life expectancy globally
Scope Of The Report
Report Attributes
Report Details
Report Title
H2-Receptor Antagonists Market Research Report
By Type
Tablets, Solutions, Injectable, Others
By Application
Hospitals, Clinics
By Companies
Tocris Bioscience, GlaxoSmithKline, Modi Lifecare Industries, Merck & Company, Apex Biotechnology, Axon Medchem, Medochemie, Tocris Bioscience
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global H2-Receptor Antagonists Market Report Segments:
The global H2-Receptor Antagonists market is segmented on the basis of:
Types
Tablets, Solutions, Injectable, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Tocris Bioscience
- GlaxoSmithKline
- Modi Lifecare Industries
- Merck & Company
- Apex Biotechnology
- Axon Medchem
- Medochemie
- Tocris Bioscience
Highlights of The H2-Receptor Antagonists Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Solutions
- Injectable
- Others
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the H2-Receptor Antagonists Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
H2-receptor antagonists are medications that block the action of histamine, a chemical messenger in the body. Histamine is responsible for causing inflammation and other symptoms during allergic reactions. H2-receptor antagonists can be used to treat allergies and other conditions that are caused by histamine activity, such as hay fever, asthma, or eczema.
Some of the major companies in the h2-receptor antagonists market are Tocris Bioscience, GlaxoSmithKline, Modi Lifecare Industries, Merck & Company, Apex Biotechnology, Axon Medchem, Medochemie, Tocris Bioscience.
The h2-receptor antagonists market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 H2-Receptor Antagonists Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 H2-Receptor Antagonists Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 H2-Receptor Antagonists Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the H2-Receptor Antagonists Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global H2-Receptor Antagonists Market Size & Forecast, 2018-2028
4.5.1 H2-Receptor Antagonists Market Size and Y-o-Y Growth
4.5.2 H2-Receptor Antagonists Market Absolute $ Opportunity
Chapter 5 Global H2-Receptor Antagonists Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 H2-Receptor Antagonists Market Size Forecast by Type
5.2.1 Tablets
5.2.2 Solutions
5.2.3 Injectable
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global H2-Receptor Antagonists Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 H2-Receptor Antagonists Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global H2-Receptor Antagonists Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 H2-Receptor Antagonists Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America H2-Receptor Antagonists Analysis and Forecast
9.1 Introduction
9.2 North America H2-Receptor Antagonists Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America H2-Receptor Antagonists Market Size Forecast by Type
9.6.1 Tablets
9.6.2 Solutions
9.6.3 Injectable
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America H2-Receptor Antagonists Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe H2-Receptor Antagonists Analysis and Forecast
10.1 Introduction
10.2 Europe H2-Receptor Antagonists Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe H2-Receptor Antagonists Market Size Forecast by Type
10.6.1 Tablets
10.6.2 Solutions
10.6.3 Injectable
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe H2-Receptor Antagonists Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific H2-Receptor Antagonists Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific H2-Receptor Antagonists Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific H2-Receptor Antagonists Market Size Forecast by Type
11.6.1 Tablets
11.6.2 Solutions
11.6.3 Injectable
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific H2-Receptor Antagonists Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America H2-Receptor Antagonists Analysis and Forecast
12.1 Introduction
12.2 Latin America H2-Receptor Antagonists Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America H2-Receptor Antagonists Market Size Forecast by Type
12.6.1 Tablets
12.6.2 Solutions
12.6.3 Injectable
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America H2-Receptor Antagonists Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) H2-Receptor Antagonists Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) H2-Receptor Antagonists Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) H2-Receptor Antagonists Market Size Forecast by Type
13.6.1 Tablets
13.6.2 Solutions
13.6.3 Injectable
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) H2-Receptor Antagonists Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 H2-Receptor Antagonists Market: Competitive Dashboard
14.2 Global H2-Receptor Antagonists Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Tocris Bioscience
14.3.2 GlaxoSmithKline
14.3.3 Modi Lifecare Industries
14.3.4 Merck & Company
14.3.5 Apex Biotechnology
14.3.6 Axon Medchem
14.3.7 Medochemie
14.3.8 Tocris Bioscience
